Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01923285 · ClinicalTrials.gov registry record · NA
A Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb Pain
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT01923285 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 152 participants.
The verdict
NCT01923285, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the AXIUM Neurostimulator System for the treatment of chronic lower limb pain in persons diagnosed with Complex Regional Pain Syndrome (CRPS) or Peripheral Causalgia (PC).
Interventions
- DEVICE AXIUM Neurostimulator System
- DEVICE Control Spinal Cord Stimulation Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01923285
The ClinicalTrials.gov registry entry for NCT01923285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AXIUM Neurostimulator System is the first listed.
NCT01923285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01923285 about?
NCT01923285 is a clinical study titled "A Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb Pain". The purpose of this study is to evaluate the safety and effectiveness of the AXIUM Neurostimulator System for the treatment of chronic lower limb pain in persons diagnosed with Complex Regional Pain Syndrome (CRPS) or Peripheral Causalgia (PC).
What is the current status of trial NCT01923285?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2013-08. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01923285?
The interventions under investigation include: AXIUM Neurostimulator System (DEVICE), Control Spinal Cord Stimulation Device (DEVICE).
Who is sponsoring clinical trial NCT01923285?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.